open-label BE trials maintain blindness [Study Per­for­mance]

posted by ElMaestro  – Denmark, 2023-10-14 19:39 (467 d 15:53 ago) – Posting: # 23755
Views: 3,464

Hi kimhaung,

❝ How do open-label BE trials maintain blindness until the database is locked?


I had a small coughing fit reading this line :-)

Can I ask:
  1. Who do you want to keep blind and why? Monitor, PI, bioanalytical staff, QA, sponsor, PK staff, statistics staff, pharmacy staff, clinical staff etc?
  2. Are the people who create the rand. code also the people who do NCA? is it the same people who do stats?
  3. Who has access to the rand. code? I do not mean who should have access.
  4. Do some of the staff with access to the rand. code also undertake other functions by any chance?

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,368 posts in 4,908 threads, 1,680 registered users;
107 visitors (0 registered, 107 guests [including 7 identified bots]).
Forum time: 10:33 CET (Europe/Vienna)

The mediocre teacher tells.
The good teacher explains.
The superior teacher demonstrates.
The great teacher inspires.    William Arthur Ward

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5